Viewing Study NCT00004397



Ignite Creation Date: 2024-05-05 @ 11:20 AM
Last Modification Date: 2024-10-26 @ 9:04 AM
Study NCT ID: NCT00004397
Status: COMPLETED
Last Update Posted: 2005-06-24
First Post: 1999-10-18

Brief Title: Phase I Study of Tin Mesoporphyrin in Patients on Long Term Heme Therapy for Prevention of Acute Attacks of Porphyria
Sponsor: National Center for Research Resources NCRR
Organization: Office of Rare Diseases ORD

Study Overview

Official Title: None
Status: COMPLETED
Status Verified Date: 2000-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: OBJECTIVES I Evaluate the effectiveness of tin mesoporphyrin in reducing the number of heme infusions needed to prevent acute attacks of porphyria

II Evaluate the safety and tolerability of tin mesoporphyrin in these patients
Detailed Description: PROTOCOL OUTLINE This is an unblinded study Patients start a preventive heme regimen and are followed for 6 months prior to tin mesoporphyrin The frequency of attacks is recorded

Patients receive tin mesoporphyrin once a week for 6 months Patients must avoid sunlight during treatment and for 2 months thereafter The frequency of heme infusions is reduced by half and the frequency of attacks of porphyria is monitored

Patients are followed for 6 months after last treatment

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
Secondary ID Type Domain Link
UTMB-FDR001459 None None None
UTMB-97-117 None None None